Audited Unaudited
Financial Year Ended 31 December 2014 2015 2016 2017 2018
No. of Months 12 12 12 12 6
  RM'000 RM'000 RM'000 RM'000 RM'000
 
Revenue 27,115 29,720 47,123 55,917 32,008
Cost of sales (13,909) (13,654) (27,624) (33,884) (18,835)
Gross profit 13,206 16,066 19,499 22,033 13,173
 
Other income 4,593 3,648 7,322 8,201 1,201
Administration expenses (10,776) (12,105) (18,915) (20,670) (9,565)
Finance costs (236) (307) (169) (189) (89)
Other expense- corporate expenses - - - - -
Profit before tax 6,786 7,303 7,737 9,375 4,720
 
Taxation (489) (845) 188 (1,898) (111)
Net profit for the financial year/period 6,297 6,458 7,924 7,477 4,609
 
Other comprehensive income  
Exchange translation differences for foreign operation - - (27) (26) -
Total comprehensive income for the financial year / period 6,297 6,458 7,897 7,503 4,609
 
Net profit for the financial year attributable to:  
Owners of the parent 6,433 6,796 8,489 7,865 4,781
Non-controlling interests (136) (338) (565) (388) (172)
6,297 6,458 7,924 7,477 4,609
 
Total comprehensive income for the year/period attributable to:  
Owners of the parent - 6,796 8,462 7,891 4,781
Non-controlling interests - (338) (565) (388) (172)
6,297 6,458 7,897 7,503 4,609
 
Gross EPS (sen) (1) 4.41 3.47 2.92 2.72 1.63
Net EPS (sen) (2) 1.77 1.47 1.27 0.97 0.59
Basic EPS (sen) (3) 1.77 1.55 1.28 0.98 0.59

Notes:-

^ Certain comparative figures have been reclassified where necessary to conform with the presentation for FYE 31 December 2013.
(1) Calculated based on gross profit divided by the number of Shares in issue.
(2) Calculated based on net profit attributable to owners of the parent divided by the number of Shares in issue.
(3) Calculated based on net profit attributable to owners of the parent divided by the weighted average number of ordinary shares in issue.

* Please read this section in conjunction with Bioalpha Holdings Berhad's Prospectus dated 26 March 2015, Annual Reports and the latest Quarterly Report.